CRISP-Disp Leverages CRISPR-Cas9 to Deliver RNA Structures to Targets in the Genome

The most comprehensive genomic analysis of the human brain ever undertaken has revealed new insights into the changes it undergoes through development, how it varies among individuals, and the roots of neuropsychiatric illnesses such as autism spectrum disorders and schizophrenia.

Study used blood test to identify distinct molecular signatures of disease; paves the way to precision medicine for cystic fibrosis.

A slow-growing brain tumor arising in patients affected by neurofibromatosis type 1 (NF1) may be vulnerable to immunotherapy, which gives the immune system a boost in fighting cancer.